Rhythm Pharmaceuticals, Inc. · NASDAQ:RYTM
Jean Christophe sold 10,000 Rhythm Pharmaceuticals, Inc. shares (Form 4)
Traded Nov 17, 2026 · Filed Nov 18, 2026
On Nov 17, 2026, Jean Christophe (Director) sold 10,000 Rhythm Pharmaceuticals, Inc. shares at an average US$109.66 for US$1.1M under a trading plan, leaving 11,712 shares. Filed Nov 18, 2026 (Form 4).
- Sold
- 10,000 shares
- Price
- US$109.66 average (US$106.81 to US$115.00)
- Value
- US$1.1M
- Holding after
- 11,712 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Common Stock | Option exercise | 10,000 | US$34.89 | 21,712 | Direct |
| Nov 17, 2026 | Common Stock | Sale | 5,000 | US$106.81 | 16,712 | Direct |
| Nov 17, 2026 | Common Stock | Sale | 2,500 | US$110.00 | 14,212 | Direct |
| Nov 17, 2026 | Common Stock | Sale | 2,500 | US$115.00 | 11,712 | Direct |
Source
Download original · View original at SEC
Related
- Rhythm Pharmaceuticals, Inc.
- Jean Christophe
- Rhythm Pharmaceuticals, Inc. shareholders
- Form 4 · Jean Christophe · Jun 25, 2026
- Form 4 · Shulman Joseph · Nov 20, 2026
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Meeker David P · Sep 14, 2026
- Form 4 · Smith Hunter C · Sep 1, 2026
- Form 4 · Shulman Joseph · Aug 17, 2026